Paraskevi Vogiatzi

ORCID: 0000-0001-9971-1619 · 5 papers in corpus
2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12112611

Despite the advances in the field of reproductive medicine, implantation failure represents a challenging condition affecting 10-30% of patients subjected to in vitro fertilization (IVF). Research has focused on the identification of molecu…

2019
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-019-01498-7

PurposeTo construct and validate an efficient artificial neural network (ANN) based on parameters with statistical correlation to live birth, to be used as a comprehensive tool for the prediction of the clinical outcome for patients undergo…

2017
In vivo (Athens, Greece) ·doi:10.21873/invivo.11050

Background/aimMild stimulation protocols have been implemented to be offered to subfertile patients who respond poorly to ovarian stimulation. We aimed to compare the efficacy of mild versus conventional gonadotropin-releasing hormone (GnRH…

review 2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd004832.pub4

BACKGROUND: Aspirin is used with the aim of optimising the chance of live birth in women undergoing assisted reproductive technology (ART), despite inconsistent evidence of its efficacy and safety (in terms of intraoperative bleeding during…

2013
International journal of endocrinology ·doi:10.1155/2013/704967

Granulocyte macrophage colony stimulating factor (GM-CSF) is a cytokine/growth factor produced by epithelial cells that exerts embryotrophic effects during the early stages of embryo development. We performed a systematic review, and six st…